Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 13.0 | 0.0 | 1.1 |
| Revenue growth | | -100.0% | |
| Cost of goods sold | 34.2 | 0.8 | 2.0 |
| Gross profit | -21.2 | -0.8 | -0.9 |
| Gross margin | -162.8% | | -87.4% |
| Selling, general and administrative | | 0.0 | |
| Sales and marketing | 11.1 | 0.0 | 1.4 |
| Research and development | 2.9 | | |
| General and administrative | 24.7 | 0.0 | 4.6 |
| EBIT | -59.8 | -0.8 | -7.4 |
| EBIT margin | -459.5% | | -684.1% |
| Pre-tax income | -72.5 | -0.5 | -7.7 |
| Income taxes | 0.2 | 0.0 | 0.0 |
| Tax rate | | | 0.0% |
| Net income | -72.7 | -0.5 | -7.7 |
| Net margin | -558.1% | | -714.5% |
| |
| Diluted EPS | ($2.89) | ($0.23) | ($2.33) |
| Shares outstanding (diluted) | 25.2 | 2.2 | 3.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|